The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTandem Group Regulatory News (TND)

Share Price Information for Tandem Group (TND)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 175.00
Ask: 180.00
Change: 0.00 (0.00%)
Spread: 5.00 (2.857%)
Open: 177.50
High: 177.50
Low: 177.50
Prev. Close: 177.50
TND Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Total Voting Rights

19 May 2022 07:00

RNS Number : 0209M
Tandem Group PLC
19 May 2022
 

19 May 2022

 

 Tandem Group plc

(the "Company" or "Group")

 

Appointment of Chief Executive Officer

 

Tandem Group plc (AIM: TND), designers, developers and distributors of sports, leisure and mobility equipment, is delighted to announce the appointment of Peter Kimberley as Chief Executive Officer of the Company with immediate effect.

Peter Kimberley was appointed as a non-executive director of the Company in November 2021 and has more than 30 years retail experience across a number of sectors including the cycle retail sector with specific experience in e-mobility across omnichannel, B2B and B2C offerings - most recently as Chief Executive Officer of Pure Electric Limited, a specialised omnichannel retailer of e-bikes and e-scooters in the UK and Europe.

Peter was previously Managing Director of Cycle Republic (omnichannel), Tredz (online proposition) and Boardman Bikes (brand and design) within Halfords Group PLC between 2013 and 2020. 

Steve Grant, Chairman, commented "We are very pleased that Peter has decided to become CEO. Having been a Non-Executive Director for 6 months, he already has a strong understanding of the business and will be able to add real value, utilising his wide and varied experience in senior leadership roles will serve to drive the Group's strategic direction and maximise shareholder value."

To facilitate an orderly transition of executive duties, Steve Grant will remain Executive Chairman until the conclusion of the Company's annual general meeting to be held on 23 June 2022, at which point he will resume his role of Non-Executive Chairman.

 

In connection with his appointment, Mr. Kimberley has today been awarded 37,500 options to subscribe for ordinary shares in the Company under the Company's 2019 Employee Share Option Scheme (the "Options"). Any future exercises of Options will be satisfied from existing ordinary shares held in treasury by the Company.

 

The Options are exercisable from 31 December 2024 at a price of 325 pence per ordinary share.

 

In addition, Mr Kimberley has been awarded 37,500 ordinary shares in the Company, These ordinary shares cannot be sold within 12 months and thereafter only with agreement from the Board. These shares will be satisfied by the transfer of ordinary shares held by the Company in treasury.

 

Following the above transaction, the Company continues to have a total of 6,013,480 ordinary shares in issue, each carrying the right to one vote. On 3 May 2022 a further 17,000 options to subscribe for ordinary shares were exercised by an employee of the Group under the 2019 Employee Share Option Scheme, which were satisfied from existing ordinary shares held in treasury. As a result, 603,921 ordinary shares are currently held in treasury. The total number of voting rights in the Company is therefore 5,409,559 which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Following the issue, Mr Kimberley holds 37,500 ordinary shares representing approximately 0.69% of the Company's issued ordinary share capital.

 

The notification set out below, made in accordance with the requirements of Article 19 of the Market Abuse Regulation, provides further details of such dealings.

 

Enquiries:

 

Tandem Group plc

David Rock, Company Secretary

Telephone 0121 748 8075

 

Nominated Adviser

Cenkos Securities plc (Nominated Adviser and Broker)

Ben Jeynes / Dan Hodkinson - Corporate Finance

Michael Johnson / Russell Kerr - Sales

Telephone 020 7397 8900

 

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Peter Kimberley

2

Reason for notification

a.

Position/Status

Chief Executive Officer

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Tandem Group plc

b.

LEI

213800WKK3A6NMOB6788

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 25p each

 

ISIN: GB00B460T373

b.

Nature of the transaction

1. Award of options to subscribe for new ordinary shares at 325 pence per ordinary share

2. Award of ordinary shares

 

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. Nil

2. Nil

37,500

37,500

 

d.

Aggregated information

- Aggregated Volume

- Price

N/A - single transactions

 

 

 

 

e.

Date of the transaction

1. 19 May 2022 

2. 19 May 2022

f.

Place of the transaction

1. Outside of a trading venue 

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company take responsibility for this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDUIGBDGDI
Date   Source Headline
28th Jun 20217:00 amRNSChange of Adviser
25th Jun 20217:00 amRNSResult of AGM
24th Jun 20217:00 amRNSAGM Statement
21st Jun 20217:00 amRNSAGM Arrangements
11th Jun 202112:57 pmRNSDirector/PDMR Shareholding
2nd Jun 20212:09 pmRNSTotal Voting Rights
2nd Jun 20217:00 amRNSTrading Update, AGM arrangements and Board Change
29th Apr 20217:00 amRNSGrant of Share Options
23rd Apr 20212:12 pmRNSHolding(s) in Company
23rd Apr 20212:09 pmRNSExercise of Options and Directors’ Shareholdings
31st Mar 20213:45 pmRNSTotal Voting Rights
29th Mar 20215:53 pmRNSDirector/PDMR Shareholding
25th Mar 20217:01 amRNSExercise of Options and Directors’ Shareholdings
25th Mar 20217:00 amRNSFinal Results
11th Mar 20217:00 amRNSAcquisition of freehold land
9th Feb 202110:32 amRNSHolding(s) in Company
9th Feb 20217:00 amRNSTrading Update and Notice of Results
31st Dec 20201:14 pmRNSHolding(s) in Company
31st Dec 20207:00 amRNSTotal Voting Rights
23rd Dec 20205:37 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSHolding(s) in Company
21st Oct 202012:41 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSHolding(s) in Company
9th Oct 20207:00 amRNSDirectorate Change
30th Sep 20203:09 pmRNSHolding(s) in Company
22nd Sep 20207:00 amRNSHalf-year Report
21st Sep 20207:00 amRNSProposed Director Appointment
28th Aug 20207:00 amRNSTrading Update and Investor Meeting
10th Aug 20204:38 pmRNSHolding(s) in Company
6th Aug 202010:43 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSDirectorate Change
25th Jun 20201:09 pmRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
10th Jun 20209:45 amRNSShareholder Statement
28th May 20207:00 amRNSTrading Update and AGM arrangements
12th May 20203:46 pmRNSHolding(s) in Company
26th Mar 20207:00 amRNSFinal Results
18th Mar 20202:39 pmRNSHolding(s) in Company
28th Feb 202012:45 pmRNSTotal Voting Rights
10th Feb 20207:00 amRNSTrading Update and Board Changes
13th Jan 202011:44 amRNSHolding(s) in Company
13th Jan 202011:42 amRNSHolding(s) in Company
10th Jan 20203:34 pmRNSHolding(s) in Company
10th Jan 202011:19 amRNSHolding(s) in Company
24th Dec 20197:00 amRNSHolding(s) in Company
30th Sep 20197:01 amRNSHalf Yearly Report
30th Sep 20197:00 amRNSBoard Change
5th Aug 20197:00 amRNSHolding(s) in Company
27th Jun 20194:15 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.